MAPK8 and Insulin resistance: As NDGA has been reported to inhibit protein kinase C [53] and JNK [18, 54] activities, it is likely that the NDGA attenuation of hepatic insulin resistance observed in the current studies involves inhibition of one or both of these kinases.